1. Home
  2. LOAN vs TIL Comparison

LOAN vs TIL Comparison

Compare LOAN & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Manhattan Bridge Capital Inc

LOAN

Manhattan Bridge Capital Inc

HOLD

Current Price

$4.23

Market Cap

48.2M

Sector

Real Estate

ML Signal

HOLD

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

N/A

Current Price

$8.15

Market Cap

54.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LOAN
TIL
Founded
1989
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.2M
54.8M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
LOAN
TIL
Price
$4.23
$8.15
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$125.00
AVG Volume (30 Days)
24.3K
30.1K
Earning Date
04-16-2026
05-08-2026
Dividend Yield
10.06%
N/A
EPS Growth
N/A
6.06
EPS
0.11
N/A
Revenue
$8,666,307.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$38.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.13
$5.67
52 Week High
$5.85
$42.75

Technical Indicators

Market Signals
Indicator
LOAN
TIL
Relative Strength Index (RSI) 42.95 50.03
Support Level $4.14 $7.95
Resistance Level $4.48 $8.30
Average True Range (ATR) 0.08 0.18
MACD 0.01 0.02
Stochastic Oscillator 27.50 62.16

Price Performance

Historical Comparison
LOAN
TIL

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: